CAYUGA BIOTECH

Cayuga Biotech is a startup developing novel hemostatic drugs and devices to reduce uncontrollable bleeding which is a leading cause of death from traumatic injuries. The company's polyphosphate-based drug accelerates the body's own clotting process to contain clotting at the injury site and thus minimize the risk of side effects. Cayuga is developing drugs for indications that treat traumatic hemorrhage as well as rare bleeding disorders.

#People #Financial #Event #Website #More

CAYUGA BIOTECH

Industry:

Biotechnology Health Care Medical Medical Device

Founded:

2015-01-01

Address:

Bridgewater, New Jersey, United States

Country:

United States

Website Url:

http://www.cayugabiotech.com

Total Employee:

11+

Status:

Active

Total Funding:

250 K USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon Content Delivery Network Font Awesome Mobile Non Scaleable Content Google Apps For Business

Current Employees Featured

damien-kudela_image

Damien Kudela
Damien Kudela Co-Founder and CSO @ Cayuga Biotech
Co-Founder and CSO
2014-01-01

kyle-ploense_image

Kyle Ploense
Kyle Ploense Head of Research & Development, CTO @ Cayuga Biotech
Head of Research & Development, CTO
2015-05-01

not_available_image

Andrea Ashford-Hicks
Andrea Ashford-Hicks Chief Executive Officer @ Cayuga Biotech
Chief Executive Officer
2022-02-01

Founder

damien-kudela_image

Damien Kudela

kyle-ploense_image

Kyle Ploense

Investors List

sosv_image

Key Employee Changes

Date	New article
2022-03-03	Cayuga Biotech Appoints Andrea Ashford-Hicks as Chief Executive Officer

Official Site Inspections

http://www.cayugabiotech.com

Host Informations
Whois Informations

Loading ...